Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD

Go back to Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
(NASDAQ: CMND) Delayed: 2.30 --0 (-0%)
Previous Close $2.30    52 Week High
Open $2.30    52 Week Low
Day High $2.30    P/E N/A 
Day Low $2.30    EPS
Volume 6,065